According to CRISPR Therapeutics's latest financial reports the company's current revenue (TTM) is $0.37 B. In 2022 the company made a revenue of $0.43 M a decrease over the years 2021 revenue that were of $0.91 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.37 B | 84762.39% |
2022 | $0.43 M | -99.95% |
2021 | $0.91 B | 168054.88% |
2020 | $0.54 M | -99.81% |
2019 | $0.28 B | 9169.85% |
2018 | $3.12 M | -92.38% |
2017 | $40.99 M | 693.9% |
2016 | $5.16 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |